Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

Hikal board declares 30% interim dividendqrcode

Jan. 18, 2008

Favorites Print
Jan. 18, 2008
The board of directors of Hikal at its meeting held on Jan. 17, 2008, declared 30% interim dividend i.e. Rs 3 a share on the equity share capital of the company for the year 2007-08.
Hikal, is in the business of providing a broad spectrum of R&D and custom manufacturing solutions to the pharmaceuticals, biotech, agrochemicals and specialty chemicals industries. The company was incorporated on Jul. 8, 1988.
It supplies molecules for discovery research on a contract basis, develops non-infringing processes and scales them up to commercial scale production, undertakes method validation of new substances and custom manufacturing of key intermediates and active substances for pharmaceutical and agrochemical companies worldwide.
Shares of the company gained Rs 2.75, or 0.57%, to trade at Rs 483.00. The total volume of shares traded was 4,610 at the BSE. (3.15 p.m., Thursday)
Source: IRIS


More from AgroNewsChange

Hot Topic More

Subscribe Comment


Subscribe Email: *
Mobile Number:  





Subscribe AgroNews Daily Alert to send news related to your mailbox